SCHEDULE 13D/A
SCHEDULE 13D/ASchedule 13D ownership disclosure
IN8BIO INC
Common Stock, par value $0.0001 per share · CUSIP: 45674E109
Event date: 2025-12-22
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BIOS Fund II, LPReported CIK 0001714576
Shares: 19,147.00 · Class: 0.2%
- BIOS Fund II QP, LPReported CIK 0001716869
Shares: 62,554.00 · Class: 0.6%
- BIOS Fund II NT, LPReported CIK 0001728851
Shares: 8,373.00 · Class: 0.1%
- BIOS Incysus Co-Invest I, LPReported CIK 0001740029
Shares: 33,247.00 · Class: 0.3%
- BIOS Fund III, LPReported CIK 0001791917
Shares: 19,024.00 · Class: 0.2%
- BIOS Fund III QP, LPReported CIK 0001791916
Shares: 124,253.00 · Class: 1.3%
- BIOS Fund III NT, LPReported CIK 0001791910
Shares: 20,066.00 · Class: 0.2%
- Bios Clinical Opportunity Fund, LPReported CIK 0001988639
Shares: 104,693.00 · Class: 1.1%
- BP Directors, LPReported CIK 0001813311
Shares: 0.00 · Class: 0.0%
- Bios Equity Partners, LPReported CIK 0001813314
Shares: 0.00 · Class: 0.0%
- Bios Equity Partners II, LPReported CIK 0001813313
Shares: 123,321.00 · Class: 1.3%
- BIOS Equity Partners III, LPReported CIK 0001831976
Shares: 163,343.00 · Class: 1.7%
- Bios Equity COF, LPReported CIK 0002000747
Shares: 104,693.00 · Class: 1.1%
- Cavu Management, LPReported CIK 0001813270
Shares: 286,664.00 · Class: 2.9%
- BIOS Capital Management, LPReported CIK 0001813845
Shares: 391,357.00 · Class: 4.0%
- Cavu Advisors, LLCReported CIK 0001813310
Shares: 286,664.00 · Class: 2.9%
- BIOS Advisors GP, LLCReported CIK 0001813844
Shares: 391,357.00 · Class: 4.0%
- Kreis Leslie W.Reported CIK 0001813316
Shares: 286,664.00 · Class: 2.9%
- Fletcher Aaron G.L.Reported CIK 0001789490
Shares: 391,357.00 · Class: 4.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001714576-25-000003
- Form type
- SCHEDULE 13D/A
- Filer
- BIOS Fund II, LP
- CIK
- CIK 1714576
- Filed
- Dec 29, 2025
- Reporting period
- Dec 22, 2025
- Description
- Schedule 13D beneficial ownership